Time-Restricted Eating for Coronary Heart Disease
(TREat-CR Trial)
Trial Summary
What is the purpose of this trial?
This study will use a form of intermittent fasting called time-restricted eating (TRE) where individuals consume ad libitum energy intake within a set window of time, commonly 8 hours, which induces a fasting window of 16 hours per day (i.e., 16:8 TRE). TRE could be an effective addition to cardiac rehabilitation as it has demonstrated cardiovascular health benefits and potential for synergy when combined with exercise training. This study will determine if TRE is a feasible and safe nutrition intervention during cardiac rehabilitation and if TRE improves the health benefits of cardiac rehabilitation compared to cardiac rehabilitation alone.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Time-Restricted Eating for Coronary Heart Disease?
Time-Restricted Eating (TRE) is suggested as a promising nutrition strategy to enhance cardiac rehabilitation (CR) by potentially improving cardiovascular health, as it involves alternating periods of fasting and eating, which may have beneficial effects on heart health. Although direct research on TRE within CR programs is limited, preliminary data from other populations indicate it could help reduce cardiovascular disease risk factors and improve outcomes when combined with exercise.12345
Is time-restricted eating safe for humans?
Time-restricted eating (TRE), which involves alternating periods of fasting and eating, has been studied for its safety and beneficial effects on heart health in various populations. Preliminary data suggest that TRE is generally safe and may have positive impacts on heart health when combined with exercise.13678
How is time-restricted eating different from standard cardiac rehabilitation for coronary heart disease?
Time-restricted eating (TRE) is a unique dietary strategy that involves eating only during specific hours each day, which may help improve heart health by reducing risk factors for heart disease. Unlike standard cardiac rehabilitation, which focuses on exercise and nutrition education, TRE offers a simpler approach that could be easier for patients to follow and may enhance the benefits of traditional rehabilitation programs.19101112
Research Team
Paul Oh, MD
Principal Investigator
University Health Network, Toronto
Amy Kirkham, PhD
Principal Investigator
University of Toronto, KITE Research Institute
Eligibility Criteria
This trial is for men and women eligible for outpatient cardiac rehabilitation due to coronary artery disease, who are willing to follow the study's procedures. It excludes those with communication barriers, night shift workers, recent mothers or pregnant women, individuals with eating disorders or very low body weight, people who eat less than 3 meals a day or have an eating window under 12 hours, and diabetics on insulin.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 16-week cardiac rehabilitation program with or without time-restricted eating (TRE). The TRE group restricts eating to an 8-hour window daily.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including adherence to TRE and cardiac rehabilitation outcomes.
Long-term Follow-up
Participants are monitored for adverse events such as re-hospitalizations and recurrent cardiac events.
Treatment Details
Interventions
- Standard cardiac rehabilitation
- Time-Restricted Eating
Standard cardiac rehabilitation is already approved in United States, European Union, Canada for the following indications:
- Secondary prevention of cardiovascular disease
- Improvement of cardiometabolic health parameters
- Cardiovascular disease management
- Rehabilitation post-myocardial infarction
- Heart disease management
- Improvement of cardiovascular risk factors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
University Health Network, Toronto
Collaborator